Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Non-Current Assets: 2015-2024

Historic Non-Current Assets for Sunshine Biopharma (SBFM) over the last 10 years, with Dec 2024 value amounting to $4.6 million.

  • Sunshine Biopharma's Non-Current Assets fell 13.62% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 13.62%. This contributed to the annual value of $4.6 million for FY2024, which is 86.98% up from last year.
  • Sunshine Biopharma's Non-Current Assets amounted to $4.6 million in FY2024, which was up 86.98% from $2.5 million recorded in FY2023.
  • Sunshine Biopharma's Non-Current Assets' 5-year high stood at $4.6 million during FY2024, with a 5-year trough of $7,061 in FY2021.
  • Moreover, its 3-year median value for Non-Current Assets was $2.5 million (2023), whereas its average is $3.0 million.
  • In the last 5 years, Sunshine Biopharma's Non-Current Assets crashed by 63.85% in 2021 and then spiked by 27,254.68% in 2022.
  • Over the past 5 years, Sunshine Biopharma's Non-Current Assets (Yearly) stood at $19,531 in 2020, then crashed by 63.85% to $7,061 in 2021, then spiked by 27,254.68% to $1.9 million in 2022, then increased by 27.20% to $2.5 million in 2023, then spiked by 86.98% to $4.6 million in 2024.